Loading organizations...
Loading organizations...
eVisit is a technology company.
eVisit develops an integrated virtual care platform designed for health systems and hospitals, offering an end-to-end solution for digital healthcare delivery. The platform provides a comprehensive suite of tools that enable healthcare providers to manage and conduct virtual patient visits, streamline workflows, and scale their telehealth programs effectively. It focuses on simplifying the process of remote diagnosis and treatment, providing a unified system for enterprise-level care.
The company was co-founded by Bret Larsen, who serves as CEO, and Miles Romney, the CTO. Their collaboration launched the eVisit Virtual Care platform with an initial insight to simplify healthcare delivery and create a comprehensive, non-competing telehealth solution. This foundational vision aimed to disrupt existing healthcare complexities by offering a dedicated and robust digital infrastructure for medical institutions.
eVisit's product serves health systems and hospitals seeking to expand and optimize their digital care capabilities. The company’s long-term vision centers on transforming healthcare by empowering these organizations to embrace and scale virtual care programs. It anticipates a future where accessible and efficient digital healthcare delivery becomes a standard, supporting providers in reaching more patients with quality care.
eVisit has raised $114.0M across 7 funding rounds.
eVisit has raised $114.0M in total across 7 funding rounds.
# eVisit: Digital Care Transformation Platform
eVisit is a virtual care platform that enables healthcare systems to scale digital care delivery across multiple service lines while optimizing clinical workflows and financial performance.[1][2] The company serves large, complex healthcare delivery organizations—including several of the top 20 US health systems—by providing configurable telehealth infrastructure that integrates directly into existing clinical and operational processes.[4] Rather than replacing traditional care, eVisit augments it: healthcare organizations use the platform to deliver virtual urgent care, primary care, specialty care, pre-post operative care, and employee health services through their existing provider networks.[3]
The core problem eVisit solves is the operational fragmentation in modern healthcare delivery. Health systems struggle with capacity bottlenecks, workforce burnout, administrative overhead, and the need to respond quickly to surges in patient demand. eVisit addresses these challenges by simplifying workflows, automating administrative tasks, and connecting care teams across digital and in-person modalities—ultimately improving access, quality, and financial stability.[1][2]
eVisit operates at the intersection of two powerful healthcare trends: the shift toward virtual-first care delivery and the urgent need for operational efficiency in resource-constrained health systems.[1][2] The timing is critical—post-pandemic, health systems face simultaneous pressures: rising patient expectations for convenient care access, severe workforce shortages and burnout, and mounting financial pressure to reduce costs while maintaining quality.
eVisit's positioning as a health system-focused platform (rather than a direct-to-consumer telehealth app) reflects a broader market maturation. While consumer-facing telehealth companies proliferated in the 2010s, the real value creation increasingly lies in helping large healthcare organizations integrate virtual care into their existing operations—a more complex, higher-stakes problem that requires deep clinical and operational expertise.[4] By backing eVisit with Goldman Sachs Asset Management and integrating UPMC's innovation capabilities, the company signals confidence in this enterprise healthcare transformation thesis.[4]
eVisit is well-positioned to capture significant market share in the enterprise virtual care platform space. The company's back-to-back KLAS awards, trusted relationships with top-tier health systems, and recent acquisition of inpatient capabilities suggest it is moving beyond scheduled virtual visits into more complex, acute care scenarios—a higher-value market segment.
The key question for eVisit's trajectory is whether it can maintain its health system focus while the broader healthcare market consolidates around fewer, larger technology platforms. As EHR vendors (Epic, Cerner) and health IT giants expand their telehealth capabilities, eVisit's differentiation will depend on its ability to deliver superior clinical outcomes, faster implementation, and deeper workflow customization than larger, more rigid competitors. Its strong clinical advisory board and UPMC partnership position it well to do this, but execution at scale will be critical.
eVisit has raised $114.0M in total across 7 funding rounds.
eVisit's investors include Chase Williams, Steven Barlow, Thomas Burton, Texas Health Resources, Dunce Capital, Kickstart Fund, Matchstick Ventures, Steven Hamerslag, Jeremy Andrus, University Growth Fund, Ruminder Dhillon, Curt Roberts.
eVisit has raised $114.0M across 7 funding rounds. Most recently, it raised $45.0M Series B in September 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 21, 2021 | $45.0M Series B | Chase Williams | Steven Barlow, Thomas Burton, Texas Health Resources |
| Jun 1, 2021 | $40.0M Series B | Dunce Capital, Kickstart Fund, Matchstick Ventures | |
| Oct 1, 2020 | $14.0M Series A | Steven Hamerslag | Dunce Capital, Kickstart Fund, Matchstick Ventures, Jeremy Andrus, University Growth Fund |
| Dec 1, 2019 | $10.0M Seed | Dunce Capital, Kickstart Fund, Matchstick Ventures | |
| Jun 1, 2017 | $2.0M Other Equity | Jeremy Andrus, Ruminder Dhillon, Curt Roberts | |
| May 1, 2017 | $2.0M Seed | Dunce Capital, Kickstart Fund, Matchstick Ventures | |
| Jul 28, 2015 | $1.0M Seed | Alan Ram, Christopher Reap, Sam Blackham |